Grindeks Kalceks Suomi

Finnish subsidiary that imports and sells prescription, hospital, pharmacy and self-care medicines made at its parent's European plants

Helsinki, FinlandFounded 2023grindeks.fiWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2023
  • New on EvolcAdded 2026-10-28

About Grindeks Kalceks Suomi

Grindeks Kalceks Suomi Oy is the Finnish subsidiary of Grindeks, a pharmaceutical manufacturer headquartered in Riga, Latvia, that has operated since 1946. The subsidiary brings to Finland medicines produced at the parent group's plants in Europe.

Its portfolio consists of hospital and pharmacy medicines as well as self-care (OTC) medicines. The parent group focuses on drugs for cardiovascular and cardiac diseases, the central nervous system, diabetes, oncology and skin diseases, and sells its products in 100 countries.

The Finnish company was founded in 2023 and is based in Helsinki. Sister subsidiaries operate in Sweden, Norway and Denmark.

Product: Prescription hospital and pharmacy medicines, and self-care (OTC) medicines imported from the parent's European plants.

Public tenders won

6 tenders won since 1 Jan 2024 from 4 public buyers in Finland, worth €11.6M as awarded. From EU award notices (TED) that name Grindeks Kalceks Suomi by its registry number.

  • 8 Sep 2026 Pohjois-Pohjanmaan hyvinvointialue · Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 · €142 notice
  • 23 Apr 2025 Finnish Institute for Health and Welfare · Antibacterials, antimycobacterials and antimycotics for systemic use, part 2 · €1 notice
  • 23 Apr 2025 Finnish Institute for Health and Welfare · Analgesics and anesthetics for systemic use · €1 notice
  • 10 Mar 2025 Vankiterveydenhuollon yksikkö · Jälki-ilmoitus. Lääkevalmisteiden ja niihin rinnastettavien tuotteiden hankintaa koskeva tarjouspyyntö hankintakaudelle 2025-2026 · €6.0M notice
  • 29 Oct 2024 Finnish Institute for Health and Welfare · Various pharmaceutical products / 2024-2025 · €5.3M notice
  • 29 Mar 2024 Sansia Oy · Lääkevalmisteet Itä-Suomen yhteistyöalueelle · €258k notice

Open tenders like these →

Jobs at Grindeks Kalceks Suomi

No open positions listed right now.

More biotech & pharma companies

  • Herantis Pharma

    Develops experimental therapies for people with Parkinson’s disease
    Espoo, FinlandBiotech & pharmaFounded 2008
    New on Evolc
  • HumGel

    Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assays
    Oulu, FinlandBiotech & pharmaFounded 2026
    Young companyNew on Evolc
  • KÄÄPÄ BioTech

    Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developers
    Karjalohja, FinlandBiotech & pharmaFounded 2018
    New on Evolc
  • LignoSphere Company

    Colloidal lignin particles from kraft lignin for coating and adhesive manufacturers seeking fossil-free phenolic substitutes
    Espoo, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc
  • Linio Biotech

    Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the Nordics
    Helsinki, FinlandBiotech & pharmaFounded 2017
    New on Evolc
  • Medicortex Finland

    Develops biomarker-based diagnostic tests for traumatic brain injury and concussion
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Google Tag Manager
  • WordPress
  • jQuery